Chronic Obstructive Pulmonary Disease Moderate Clinical Trial
— COPDOfficial title:
Beetroot Juice - Effects on Performance in Chronic Obstructive Pulmonary Disease Patients
| Verified date | June 2014 |
| Source | University of Aarhus |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The purpose is to evaluate exercise performance in patients with Chronic Obstructive Pulmonary Disease (COPD) after supplementing with higher doses of dietary NO3-, compared to previous studies, as beetroot juice for seven days. The secondary purpose is to evaluate oxygen consumption of submaximal cycling, amendments in blood pressure, and physical activity level.
| Status | Completed |
| Enrollment | 15 |
| Est. completion date | August 2015 |
| Est. primary completion date | April 2014 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Moderate-severe Chronics Obstructive Pulmonary Disease (COPD) (FEV1 <80% of predicted). Exclusion Criteria: - Smoking, - failure to complete physical testing, - on-going participation in rehabilitation programs, - pacemaker or use of nicotine products, - oxygen mask, - beta blockers, - antibacterial mouthwash, - chewing gum or stomach-neutralizing medicine during the intervention. |
| Country | Name | City | State |
|---|---|---|---|
| Denmark | Sport Science, Department of Public Health, Aarhus University | Aarhus |
| Lead Sponsor | Collaborator |
|---|---|
| University of Aarhus |
Denmark,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Physical performance on 6-min walk test (6MWT) | 6 minutes | ||
| Secondary | Blood Pressure | At baseline and 150 minutes after consumption of beverages | ||
| Secondary | Plasma Nitrite concentration | Baseline, 150 and 210 minutes after consumption of beverages | ||
| Secondary | Oxygen consumption during submaximal cycling | Two trials of 6 minutes duration (10 min break between trials) | ||
| Secondary | Physical activity level | Measured all intervention days except on the day of testing | Six days |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05539547 -
Effect of NMES on Quadriceps Muscle Strength and Endurance in Patients With COPD
|
Early Phase 1 | |
| Recruiting |
NCT04386590 -
Manual Therapy in Addition to Pulmonary Rehabilitation in Moderate Chronic Obstructive Pulmonary Disease.
|
Phase 2/Phase 3 | |
| Active, not recruiting |
NCT04206007 -
Mesenchymal Stem Cells for The Treatment of Chronic Obstructive Pulmonary Disease
|
Phase 1 | |
| Completed |
NCT05259280 -
Observational Study of the Wellinks Solution Impact on Quality of Life and Clinical Outcomes in Patients With COPD
|
N/A | |
| Completed |
NCT03028142 -
The Effects of RPL554 in Addition to Tiotropium in COPD Patients
|
Phase 2 | |
| Completed |
NCT02962999 -
Effect Of Ketamine Infusion In Patients With COPD Applied One Lung Ventilation
|
Phase 4 | |
| Completed |
NCT02998944 -
The Study of CCTM and Common Diseases
|
N/A | |
| Completed |
NCT05431218 -
Association of Cathelicidin and Vitamin D Levels With the Category and Course of COPD
|
Phase 4 | |
| Active, not recruiting |
NCT06269029 -
Chest Mobility Exercises Versus Proprioceptive Neuromuscular Facilitation in Patients With COPD
|
N/A | |
| Completed |
NCT03031093 -
Aerosol Therapy in Obese COPD Patients.
|
N/A | |
| Recruiting |
NCT06072690 -
Respiratory and Cardiovascular Alterations in Patients With Chronic Obstructive Pulmonary Disease
|